Cerus Corporation, a biomedical products company focused in the field of blood transfusion safety, and its distribution partner CEI Group (Brazil) announced a donation of INTERCEPT Blood System ...

A safe blood supply is needed for many health care procedures. While low- and middle-income nations account for 82 percent of the world’s population, they collect only approximately half of the blood ...

CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq:CERS) announced today FDA regulatory approval for manufacture of INTERCEPT plasma with a new, alternative plastic disposable kit. The ...

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq:CERS) announced today it was awarded a five-year contract with the U.S. Food and Drug Administration (FDA) for the development of ...

American scientists have developed a smartphone app that can identify types of bacteria in one hour, down from a typical turnaround of 18 to 28 hours. The reduced detection time should mean faster ...

Identification of new pathogens requires a rapid response from industry to develop new tests and the FDA to assess test safety and efficacy. A report evaluates the new OpenArray system that offers ...

Blood borne pathogens pose a great risk to the health of employees if contact is made with another’s blood/bodily fluids. In general, if contact with another person’s blood or bodily fluids is ...

CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (CERS) today announced the start of the INITIATE study by the German Red Cross Blood Donation Service Baden-Württemberg – Hessen and its subsidiary ...

London [UK]: Using the Wyss Institute's FcMBL broad-spectrum pathogen capture technology, researchers have redesigned the method of microbial pathogen detection in blood samples from paediatric sepsis ...

AMSBIO announce the addition of several new products to its growing range of magnetic bead based nucleic acid extraction kits for pathogens detection. The MagSi-NA Pathogens MSP (Multiple Sample ...